Punitive Damages Against TASER International Thrown Out in Heston v. City of Salinas, et al.

Court Eliminates $5,200,000 in Punitive Damages From June 2008 Jury Verdict


SCOTTSDALE, Ariz., Oct. 27, 2008 (GLOBE NEWSWIRE) -- TASER International, Inc. (Nasdaq:TASR), the market leader in advanced electronic control devices (ECDs), announced that Judge James Ware of the United States District Court for the Northern District of California has granted TASER's Renewed Motion for Judgment with respect to the award of punitive damages. The court denied TASER's alternative motion for a new trial in the case Betty Lou Heston, et al. v. City of Salinas, TASER International, Inc. (TASER), et al. In granting the Renewed Motion for Judgment, Judge Ware threw out all punitive damages awarded in the case.

Specifically, Judge Ware ruled late Friday afternoon October 24, 2008, that:


  1. Court DENIES Defendant TASER's Rule 50 motion (motion for
     judgment as a matter of law) on all grounds, with the sole
     exception to its challenge regarding the punitive damage
     awards.

  2. Court finds Defendant TASER's Renewed Motion for Judgment
     meritorious with respect to the award of punitive damages
     to the Estate (of Robert C. Heston) and GRANTS Defendant
     TASER's motion. The Jury's award of punitive damages
     ($200,000) to the Estate will be disregarded and judgment
     will be entered accordingly.

  3. Court finds Defendant TASER's Renewed Motion for Judgment
     meritorious with respect to the award of punitive damages
     to Plaintiffs Parents and GRANTS Defendant TASER's motion.
     The Jury's award of punitive damages ($5,000,000) to the
     Plaintiffs Parents will be disregarded and judgment will be
     entered accordingly.

  4. Defendant TASER's alternative motion for a new trial is
     DENIED.

On June 6, a jury had found TASER International 15 percent responsible for the death of Mr. Robert C. Heston during an arrest on February 19, 2005 in which five law enforcement officers discharged five (5) TASER M26 ECDs deploying six (6) cartridges. The jury also found that Mr. Heston's own actions, including toxic methamphetamine ingestion, were 85 percent responsible for his death.

"TASER International is obviously very pleased with Judge Ware's ruling with respect to punitive damages, which leaves $153,150 in net compensatory damages remaining," stated Doug Klint, General Counsel for TASER International. "The jury, in this case, clearly exceeded its ability to award punitive damages which are not permitted under California law on a finding of negligent failure to warn."

"Notwithstanding the favorable ruling on these motions, TASER International will continue to consider all appropriate legal channels available in this case, including filing an appeal," added Klint.

About TASER International, Inc.

TASER International's products protect life. TASER provides advanced Electronic Control Devices (ECDs) for use in the law enforcement, medical, military, corrections, professional security, and personal protection markets. TASER devices use proprietary technology to incapacitate dangerous, combative, or high-risk subjects who pose a risk to law enforcement officers, innocent citizens, or themselves in a manner that is generally recognized as a safer alternative to other uses of force. For more information, please call TASER International at (800) 978-2737 or visit our website at www.TASER.com.

The TASER International logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=2931

Note to Investors

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including statements, without limitation, regarding our expectations, beliefs, intentions or strategies regarding the future. We intend that such forward-looking statements be subject to the safe-harbor provided by the Private Securities Litigation Reform Act of 1995. The forward-looking information is based upon current information and expectations regarding TASER International. These estimates and statements speak only as of the date on which they are made, are not guarantees of future performance, and involve certain risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results could materially differ from what is expressed, implied, or forecasted in such forward-looking statements.

TASER International assumes no obligation to update the information contained in this press release. These statements are qualified by important factors that could cause our actual results to differ materially from those reflected by the forward-looking statements. Such factors include but are not limited to: (1) market acceptance of our products; (2) our ability to establish and expand direct and indirect distribution channels; (3) our ability to attract and retain the endorsement of key opinion-leaders in the law enforcement community; (4) the level of product technology and price competition for our products; (5) the degree and rate of growth of the markets in which we compete and the accompanying demand for our products; (6) risks associated with rapid technological change and new product introductions; (7) competition; (8) litigation including lawsuits resulting from alleged product related injuries and death; (9) media publicity concerning allegations of deaths and injuries occurring after use of the TASER device and the negative effect this publicity could have on our sales; (10) TASER device tests and reports; (11) product quality; (12) implementation of manufacturing automation; (13) potential fluctuations in our quarterly operating results; (14) financial and budgetary constraints of prospects and customers; (15) order delays; (16) dependence upon sole and limited source suppliers; (17) negative reports concerning the TASER device; (18) fluctuations in component pricing; (19) government regulations and inquiries; (20) dependence upon key employees and our ability to retain employees; (21) execution and implementation risks of new technology; (22) ramping manufacturing production to meet demand; (23) medical and safety studies; (24) field test results; and (25) other factors detailed in our filings with the Securities and Exchange Commission, including, without limitation, those factors detailed in the Company's Annual Report on Form 10-K and its Form 10-Qs.

The statements made herein are independent statements of TASER International. The inclusion of any third parties does not represent an endorsement of any TASER International products or services by any such third parties.



            

Kontaktdaten